These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9224309)

  • 41. [Diagnosis and treatment of bladder cancer].
    Lopatkin NA; Darenkov SP; Chernyshev IV; Martov AG; Stupak NV
    Urologiia; 2004; (1):12-7. PubMed ID: 15022437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.
    Kamat AM; Dinney CP; Gee JR; Grossman HB; Siefker-Radtke AO; Tamboli P; Detry MA; Robinson TL; Pisters LL
    Cancer; 2007 Jul; 110(1):62-7. PubMed ID: 17542024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
    Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
    Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
    Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.
    Kamat AM; Gee JR; Dinney CP; Grossman HB; Swanson DA; Millikan RE; Detry MA; Robinson TL; Pisters LL
    J Urol; 2006 Mar; 175(3 Pt 1):881-5. PubMed ID: 16469571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer.
    Raj GV; Herr H; Serio AM; Donat SM; Bochner BH; Vickers AJ; Dalbagni G
    J Urol; 2007 Apr; 177(4):1283-6; discussion 1286. PubMed ID: 17382713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?
    Pos F; Horenblas S; Dom P; Moonen L; Bartelink H
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):678-86. PubMed ID: 15708245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience.
    Iida S; Kondo T; Kobayashi H; Hashimoto Y; Goya N; Tanabe K
    Int J Urol; 2009 Mar; 16(3):287-92. PubMed ID: 19207115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.
    Smaldone MC; Jacobs BL; Smaldone AM; Hrebinko RL
    Urology; 2008 Sep; 72(3):613-6. PubMed ID: 18554696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
    J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study.
    Koga F; Kihara K; Fujii Y; Yoshida S; Saito K; Masuda H; Kageyama Y; Kawakami S
    BJU Int; 2009 Jul; 104(2):189-94. PubMed ID: 19154452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radical therapy for muscle-infiltrating bladder cancer (cystectomy or radiotherapy): does age affect the final therapeutic benefit for the patient?
    Kalogeras D; Lampri E; Goussia A; Bai M; Capizzello A; Tassiou I; Stavropoulos NE; Tsekeris P
    J BUON; 2008; 13(3):353-8. PubMed ID: 18979549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer.
    Qureshi KN; Griffiths TR; Robinson MC; Marsh C; Roberts JT; Hall RR; Lunec J; Neal DE
    Clin Cancer Res; 1999 Nov; 5(11):3500-7. PubMed ID: 10589764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
    Gupta NP; Kolla SB; Seth A; Hemal AK; Dogra PN; Kumar R
    J Urol; 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?
    Herr HW; Sogani PC
    J Urol; 2001 Oct; 166(4):1296-9. PubMed ID: 11547061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate.
    Ferreira U; Matheus WE; Nardi Pedro R; Levi D'Ancona CA; Reis LO; Stopiglia RM; Denardi F; Rodrigues Netto N; de Cássio Zequi S; da Fonseca FP; Lopes A; Cardoso Guimarães G; de Carvalho Fernandes R; Cardenuto Perez MD
    Urol Int; 2007; 79(3):200-3. PubMed ID: 17940350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of muscle-invasive bladder cancer in Victoria, 1990-1995.
    Millar JL; Frydenberg M; Toner G; Syme R; Thursfield V; Giles GG;
    ANZ J Surg; 2006 Mar; 76(3):113-9. PubMed ID: 16626343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
    Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
    Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.